DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 5Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 2Accord Healthcare Pty. Ltd.
04 15Accord healthcare
05 4Accure Labs
06 3Actavis Inc
07 2Alembic Pharmaceuticals Limited
08 1Almaject
09 2Amneal Pharmaceuticals
10 3Aurobindo Pharma Limited
11 2Ayana Pharma
12 6BAXTER HEALTHCARE PTY LTD
13 2Baxter HealthCare South Africa (Pty) Ltd
14 5Baxter Healthcare Corporation
15 1Bayer AG
16 1Bluepharma
17 3Bristol Myers Squibb
18 2Cipla Medpro South Africa
19 1Deva Holding AS
20 1Dr Reddy's Laboratories (Pty) Ltd
21 3EBEWE Pharma Ges.m.b.H Nfg. KG
22 1EBEWE Pharma Ges.mbHNfg.KG
23 2Flagship Biotech International Pvt. Ltd
24 1Fresenius Kabi USA
25 2Fresenius SE & Co. KGaA
26 1GLAND PHARMA LIMITED
27 6GetWell Pharmaceutical
28 1Health Biotech
29 1Healthcare Pharmaceuticals
30 5Hikma Pharmaceuticals
31 1Intelliscend
32 3Janssen-Cilag
33 2Jodas Expoim Pvt. Ltd
34 3Key Oncologics
35 2Lupin Ltd
36 3Naprod Life Sciences
37 2Nishchay Pharmaceuticals Pvt. Ltd.
38 4Oethmaan Biosims
39 1PHARMOBEDIENT
40 1Panacea Biotec Limited
41 4Pfizer Consumer Healthcare
42 30Pfizer Inc
43 5Pharmachemie
44 8Pharmachemie (Pty) Ltd
45 1Pharmaplan
46 3SEACROSS PHARMACEUTICALS
47 1Sagent Pharmaceuticals
48 3Sakar Healthcare
49 7Sandoz B2B
50 10Sun Pharmaceutical Industries Limited
51 1Taro Pharmaceutical Industries
52 13Teva Pharmaceutical Industries
53 4TherDose Pharma
54 4Viatris
55 2Vinkem Labs Ltd
56 1Zhejiang Hisun Pharmaceutical
57 2Zydus Lifesciences
58 9Blank
01 4CONCENTRATE FOR SOLUTION FOR INFUSION
02 4Concentrate to the infusion fluid
03 1Concentrate to the infusion fluid, resolution
04 1Concentrated Solution
05 1Concentrated Solution Perfusion
06 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
07 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
08 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
09 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
10 1Doxorubicin 50Mg 1 Unit Parenteral Use
11 1Doxorubicin 50Mg 2 Units Parenteral Use
12 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
13 2Dry Sub
14 11INF
15 23INJ
16 16INJECTABLE, LIPOSOMAL;INJECTION
17 38INJECTABLE;INJECTION
18 6INJECTION
19 1Inf Conc
20 3Inj L?s
21 1Inj Sol
22 5Inj Solution
23 2Injectable Infusion
24 3Injectable Intravenous Solution
25 1Injectable; Injection
26 22Injection
27 5Injection fluid, resolution
28 1Liposomal Injection
29 1Liposome Injection
30 1Liquid Injection
31 2Lyo.Inj
32 2Lyophilised Injection
33 1POI
34 1POWDER FOR CONCENTRATE FOR
35 2POWDER FOR SOLUTION
36 1PULVER, DISPERSION OCH VÄTSKA TILL
37 1Powder For Oral Solution
38 1Powder and liquids to concentrate for infusion, liposomaldispersjon
39 2Powder for injection fluid, resolution
40 2SOL
41 6SOLUTION
42 2SOLUTION FOR INJECTION
43 2SUSPENSION
44 1Vial
45 1Vial Of Lyophilised
46 18Blank
01 22DISCN
02 45Generic
03 2Lead Market Dossiers- Approved in US and Under review in EU
04 1Lead Market Dossiers- Filed
05 6Originator
06 32RX
07 107Blank
01 11 Farmiblastina 10Mg Vial 1 Blister Powder And Solvent For Solution For Injection
02 11 Farmiblastina 10Mg Vial Solution + 1 Blister
03 11 Farmiblastina 50Mg Vial Of Lyophilised
04 11 Farmiblastina Solution 50Mg Vial 25Ml
05 2ADRIAMYCIN PFS
06 9Adriamycin
07 2Adriblastin RD
08 3Adriblastin Sol
09 5Adriblastina
10 1Adriblastina CSV 10mg/5ml
11 1Adriblastina CSV 50mg/25ml
12 1Adriblastina RD 10mg
13 1Adriblastina RD 50mg
14 1CAELYX
15 12Caelyx
16 1Cipla Doxorubicin 10
17 1Cipla Doxorubicin 50
18 2DOXIL (LIPOSOMAL)
19 1DOXOPEG
20 4DOXORUBA
21 1DOXORUBICIN
22 1DOXORUBICIN -SOL PCH 10MG
23 1DOXORUBICIN 10mg/5ml FRESENIUS
24 1DOXORUBICIN 50mg/25ml FRESENIUS
25 33DOXORUBICIN HYDROCHLORIDE
26 14DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
27 2DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
28 1DOXORUBICIN HYDROCHLORIDE INJECTION
29 1DOXORUBICIN INJECTION, BP
30 1DOXORUBICIN-SOL PCH 50MG
31 2DOXOTHER
32 1Doxolip
33 1Doxonish 10
34 1Doxonish 50
35 10Doxorubicin
36 1Doxorubicin "Ebewe" 10mg (5ml vial)
37 1Doxorubicin "Ebewe" 50mg (25ml vial)
38 1Doxorubicin - Pch 10
39 2Doxorubicin ACC
40 5Doxorubicin Accord
41 1Doxorubicin Accord 10mg/5ml
42 1Doxorubicin Accord 2Mg/Ml 1 Vial 50Mg/25Ml Concentr Solution Perf Efg
43 1Doxorubicin Accord 2Mg/Ml 1 Vial 50Ml Drip Soluc Concentr Efg
44 1Doxorubicin Accord 50mg/25ml
45 1Doxorubicin Actavis
46 1Doxorubicin Aurovitas 2Mg/Ml 25Ml Vial 1 (50Mg/25Ml) Concentrated Sun Perf Efg
47 1Doxorubicin Aurovitas 2Mg/Ml 50Ml Vial 1 (100Mg/50Ml) Grant Sun Perf Efg
48 4Doxorubicin Ebewe
49 2Doxorubicin Mylan
50 1Doxorubicin Pch
51 1Doxorubicin Pch 10 10Mg Vial
52 1Doxorubicin Pch 50
53 1Doxorubicin Rtu
54 1Doxorubicin Rtu 10-5 5Ml
55 1Doxorubicin Rtu 200-100 100Ml
56 1Doxorubicin Rtu 50-25 25Ml
57 4Doxorubicin Sandoz eco
58 1Doxorubicin Tedec 2Mg/Ml 25Ml Vial Soluc 1 Pb
59 1Doxorubicin hcl faulfing powder vial
60 1Doxorubicin-Hexal 10Mg/5Ml
61 1Doxorubicin-Hexal 50Mg/25Ml
62 2Doxorubicin-Teva
63 1Doxred 10 Lyophilized Powder
64 1Doxred 10mg/5ml
65 1Doxred 50 Lyophilized Powder
66 1Doxred 50mg/25ml
67 2I-DOX
68 6Liposomal Doxorubicin SUN
69 3Myocet
70 3RUBEX
71 1Rubexet 10mg/5ml
72 1Rubexet 200mg/100ml
73 1Rubexet 50mg/25ml
74 1Sopilcin 20 mg/10 ml
75 1TARO-DOXORUBICIN LIPOSOMAL
76 1doxorubicin
77 29Blank
01 18Australia
02 7Canada
03 35India
04 17Italy
05 13Norway
06 1Portugal
07 37South Africa
08 9Spain
09 8Sweden
10 12Switzerland
11 1Turkey
12 54USA
13 3United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2017-05-15
Application Number : 208657
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20MG/10ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG/25ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US and Under review in EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 20MG/10ML (2MG/ML)
Packaging :
Approval Date : 1995-11-17
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXIL (LIPOSOMAL)
Dosage Form : INJECTABLE, LIPOSOMAL;INJECTION
Dosage Strength : 50MG/25ML (2MG/ML)
Packaging :
Approval Date : 2000-06-13
Application Number : 50718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RUBEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-04-13
Application Number : 62926
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1989-03-17
Application Number : 62921
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date : 1985-05-20
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/VIAL
Packaging :
Approval Date : 1987-07-22
Application Number : 50467
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 2MG/ML
Packaging :
Approval Date : 1987-12-23
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 200MG/100ML
Packaging :
Approval Date : 1988-05-03
Application Number : 50629
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXORUBICIN HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 150MG/75ML
Packaging :
Approval Date : 2011-03-28
Application Number : 50629
Regulatory Info : DISCN
Registration Country : USA
